References
- Hypertension mechanism Irvine H;Page MD.
- Hypertension(Second Edition) Jacques G;Otto K;Pavel H;Marc C.
- Clin. Sci. v.60 no.4 Adrenergic facilitation by angiotensin: does it serve a physiological function? Zimmerman BG.
- Hypertension v.11 no.3 Local generation and release of angiotensin II in peripheral vascular tissue Mizuno K;Nakamura M;Higashimori K; Inagami T.
- Hypertension v.20 no.2 Tissue renin-angiotensin systems in renal hypertension Nishimura M;Milsted A;Block CH;Brosnihan KB;Ferrario CM.
- Biochem. pharmacol. v.27 no.5 Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase Erdos EF;Johnson A;Boyden NT.
- J. Hypertens. Suppl. v.12 no.2 Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study Lacoureiere Y;Lefebvre J;Nakhle G;Faison EP;Snavely DB;Nelson EB.
- Vasc. Med. v.1 no.2 The impact of angiotensin converting enzyme inhibitors on the arterial wall Lee AF;Struthers AD.
- Am. J. Cardiol. v.75 no.12 Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension Goldberg AI;Dunlay MC;Sweet CS.
- Br. J. Clin. Pharmacol. v.46 no.2 Start of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor Scholze J;Stapff M.
- Lancet. v.349 no.9054 Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Pitt B;Segal R;Martinez FA;Meurers G;Cowley AJ;Thomas I;Deedwania PC;Ney DE;Snavely DB;Chang PI.
- J. Vet. Med. Sci. v.54 no.1 Early development of spontaneous glomerular lesion in Syrian hamsters of APA strain Han JS;Norimatsu M;Itagaki S;Doi K.
- Lab Anim. v.24 no.1 Glomerular lipidosis in a Syrian hamster of the APA strain Norimatsu M;Doi M;Itagaki S;Honjo K;Mitsuoka T.
- Hypertension v.19 Increased vascular formation of angiotensin II in one-kidney, one clip hypertension Leite R;Salgado MC.
- Am. J. Cli. Pathol. v.66 no.2 A sensitive fluorimetric assay for serum angiotensin-converting enzyme Friedland J;Silverstein E.
- Hypertension An improved fluorometric assay of rat serum and plasma converting enzyme Santos RAS;Krieger EM;Greene LJ.
- Biol. Pharm. Bull. v.23 no.2 Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models Tokioka T;Shibasaki M;Fujimori A;Matsuda-Satoh Y;Uchida W;Inagaki O;Yanagisawa I.
- American Journal of Pathology v.88 no.3 Morphometric analysis of hypertension induced hypertrophy of rat thoracic aorta Wiener J;Loud AV;Giacomelli F;Anversa P.
- The Journal of Pharmacology and Experimental Therapeutics v.284 no.3 Antihypertensive and Natriuretic Effects of CGS 30440, a Dual Inhibitor of Angiotensin Converting Enzyme and Neutral Endopeptidese 24.11 Ricardo EC;Rajendra DG;Angelo JT;Lynne MO;Beatriz ND;Stephane De L;Rodney WL;Cynthia AF.
- The Journal of Pharmacology and Experimental Therapeutics v.291 no.1 Angiotensin II-Induced Renal Vasoconstriction in Genetic Hypertension Edwin KJ;William AH;Subharsh JV;CURTIS KK.